FDA Inspection
Nanjing White Whale Pharmaceutical Co., Ltd.Nanjing White Whale Pharmaceutical Co., Ltd. – FDA Inspection, Jul 21, 2017
Record Details
This FDA Inspection record concerns Nanjing White Whale Pharmaceutical Co., Ltd., with an inspection on July 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 701350ce-be1f-40fa-9bd5-fc4b3e9e5672
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1020941
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Nanjing White Whale Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 25, 2024 | Not classified | Office of Inspections and Investigations | |
| September 19, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nanjing White Whale Pharmaceutical Co., Ltd.
- FDA Inspection 1228562 - 2024-01-25
- FDA Inspection 898126 - 2014-09-19
- FDA Inspection 728992 - 2011-06-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.